PURE BiosciencePURE 
$0.06-14.29%24h
-14.29%24h
Global rank33851
Market cap$6.68M
Change 7d-14.29%
YTD Performance-57.14%
SP500 benchmarkUnderperform
P/E-1.50
P/S3.56
Revenue$1.88M
Earnings-$3.96M
Dividend yield-
Main Sector
Consumer Defensive
PURE Bioscience (PURE) Cash on Hand
PURE Cash on Hand in 2022: $1.09M
According to PURE Bioscience latest financial reports the cash on hand of PURE is $1.09M, an decrease of -67.71% to 2022. At the end of 2022 company had $3.39M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
PURE Cash on Hand History from 2019 to 2023
-
Value:-
PURE Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $1.09M | -67.71% |
| 2022 | $3.39M | 41.88% |
| 2021 | $2.39M | -37.74% |
| 2020 | $3.84M | 864.57% |
| 2019 | $398.00K | - |
View the Top Cash on Hand Companies 
